The objective of the research project presented in this webinar was to determine if the three primary methods of production for a typical biosimilar (batch, fed-batch, and perfusion) may be simply and easily executed using a single, benchtop bioprocess control system to allow confident process decisions that are scalable to full production. We compared two perfusion processes. For the fed-batch and perfusion cultivations, we used stirred-tank single-use bioreactors.
This webinar will discuss the outcome of these studies, and will provide an analysis of the benefits of their respective usage in biosimilar production with a particular focus on improving time and cost efficiency.
This webinar took place on Tuesday June 14th 2016